Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

OsteoArthritis and Therapy for Sleep (OATS)

1 april 2020 bijgewerkt door: Michael Vitiello, University of Washington

Efficacy of Scalable CBT for Insomnia in Older Adults With Osteoarthritis Pain

Osteoarthritis (OA) pain affects 50 percent of older adults, more than half of whom also experience significant sleep disturbance. This randomized trial will determine whether a telephone-based cognitive behavioral treatment targeting insomnia in older adults with chronic severe OA-related insomnia and pain results in substantially greater reductions in insomnia severity and in related improvements in pain, fatigue, mood, quality of life and healthcare costs compared to telephone-delivered education (attention control) about insomnia. The trial will test an intervention that if demonstrated to have long term efficacy is scalable and has the potential for wide-scale deployment in healthcare systems.

Studie Overzicht

Toestand

Onbekend

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

Twenty-five percent of older adults experience significant osteoarthritis (OA)-related comorbid sleep disturbance. Insomnia is associated with substantial negative effects on function, mood, and medical resource utilization. Cognitive behavioral therapy for insomnia (CBT-I) is evidence based and has been shown to be efficacious in populations with a variety of comorbid conditions including OA-related chronic pain. However, in-person CBT interventions are unlikely to be widely deployable in healthcare systems. Telephone delivery has the advantage of giving patients access to personalized, efficacious CBT-I interventions from home, increasing generalizability, and outreach to minority, rural, and other underserved populations. Older (60+ yrs) primary care patients across Washington State will be screened for severe persistent OA-related insomnia and pain. Two hundred and seventy patients will be randomized to either CBT-I or an education only attention control (EOC). Each treatment will consist of six 20-30 minute telephone-based sessions over an eight week period. Pre-treatment, post-treatment (2 months and 12 month) assessments will include measures of sleep, pain, fatigue, mood, and quality of life. A cost effectiveness evaluation of the intervention will also be conducted. The proposed research will determine if telephone CBT-I improves OA insomnia and associated outcomes in a state-wide primary care population of older adults, and inform policy decisions about widespread dissemination of telephone CBT-I in this and related patient populations.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

327

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

  • Verenigde Staten
    • Washington
      • Seattle, Washington, Verenigde Staten, 98101
        • Kaiser Permanente Washington Research Institute

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

60 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Age 60+ with one or more health care visits for OA in the prior 3 years
  • Score of ≥6 on 4-item ISI at first screening and ≥11 on full ISI at second screening
  • Score of ≥9 on two items from the Brief Pain Inventory (BPI) asking about average pain intensity in the past 2 weeks (0-10 scale) and activity interference due to pain (0-10 scale) at first and second screening

Exclusion Criteria:

  • Not continuously enrolled at Group Health Cooperative for at least one year
  • Prior diagnosis of a primary sleep disorder: sleep apnea with an AHI/RDI score of 15+ or current use of a CPAP machine; periodic leg movement disorder; restless leg syndrome; sleep-wake cycle disturbance; or rapid eye movement behavior disorder
  • Diagnosis in the medical record of: rheumatoid arthritis, terminal disease, being considered for major surgery, active chemotherapy or radiation for cancer, or inpatient treatment for congestive heart failure within the previous 6 months
  • Diagnosis of dementia, use of acetylcholinesterase inhibitor and/or memantine for cognitive impairment, or cognitive impairment (>6 on the Short Orientation-Memory-Concentration Test)
  • Hearing or speech impairment sufficient to preclude participation in a telephone intervention

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Cognitive Behavioral Therapy
Cognitive Behavioral Therapy for Insomnia is delivered by trained sleep therapists in six telephone sessions.
Gedragsmatig: Cognitive Behavior Therapy for Insomnia
Six telephone sessions that last 20-30 minutes presenting cognitive behavioral therapy for insomnia.
Andere namen:
  • CBT-I
Actieve vergelijker: Education Control
Education Only Control is delivered by trained sleep therapists in six telephone sessions.
Gedragsmatig: Education Only Control
Six telephone sessions that last 20-30 minutes presenting sleep and osteoarthritis education.
Andere namen:
  • EOC

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Insomnia Severity Index (ISI)
Tijdsspanne: 12 months post baseline
A 7-item questionnaire that is a global measure of perceived insomnia severity. Items use a 5-point scale for total scores of 0-28, with >15 considered moderate severity.
12 months post baseline

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Insomnia Severity Index (ISI)
Tijdsspanne: 2 months post baseline
A 7-item questionnaire that is a global measure of perceived insomnia severity.Items use a 5-point scale for total scores of 0-28, with >15 considered moderate severity.
2 months post baseline
Pittsburgh Sleep Quality Index (PSQI)
Tijdsspanne: 2 months post baseline
Self-rating of overall sleep quality and disturbances using 7 sleep. components. PSQI global >5 is highly sensitive and specific for distinguishing good and poor sleepers.
2 months post baseline
Pittsburgh Sleep Quality Index (PSQI)
Tijdsspanne: 12 months post baseline
Self-rating of overall sleep quality and disturbances using 7 sleep components. PSQI global >5 is highly sensitive and specific for distinguishing good and poor sleepers.
12 months post baseline
Brief Pain Inventory-short form (BPI-sf)
Tijdsspanne: 2 months post baseline
A questionnaire to assess pain intensity and interference with activities. The BPI-sf rates pain intensity (4 items) and interference (7 items) from 0 to 10 and is validated for use in clinical trials with OA pain patients.
2 months post baseline
Brief Pain Inventory-short form (BPI-sf)
Tijdsspanne: 12 months post baseline
A questionnaire to assess pain intensity and interference with activities. The BPI-sf rates pain intensity (4 items) and interference (7 items) from 0 to 10 and is validated for use in clinical trials with OA pain patients.
12 months post baseline
Flinders Fatigue Scale (FFS)
Tijdsspanne: 2 months post baseline
A 7-item self-report questionnaire to measure fatigue level in a variety of situations.
2 months post baseline
Flinders Fatigue Scale (FFS)
Tijdsspanne: 12 months post baseline
A 7-item self-report questionnaire to measure fatigue level in a variety of situations.
12 months post baseline
Patient Health Questionnaire (PHQ-8)
Tijdsspanne: 2 months post baseline
4-point scale rates frequency of occurrence of 8 depressive symptoms.
2 months post baseline
Patient Health Questionnaire (PHQ-8)
Tijdsspanne: 12 months post baseline
4-point scale rates frequency of occurrence of 8 depressive symptoms.
12 months post baseline
Sleep Hygiene Index (SHI)
Tijdsspanne: 2 months post baseline
A 13-item scale that rates how often participants engage in specific sleep hygiene related behaviors, including continued adherence to CBT-I recommendations over time.
2 months post baseline
Sleep Hygiene Index (SHI)
Tijdsspanne: 12 months post baseline
A 13-item scale that rates how often participants engage in specific sleep hygiene related behaviors, including continued adherence to CBT-I recommendations over time.
12 months post baseline
EuroQoL 5D (EQ-5D)
Tijdsspanne: 2 months post baseline
Rates health status on five dimensions and overall health status from 0 to 100. The most widely used measure in clinical trials assessing general quality of life of OA patients.
2 months post baseline
EuroQoL 5D (EQ-5D)
Tijdsspanne: 12 months post baseline
Rates health status on five dimensions and overall health status from 0 to 100. The most widely used measure in clinical trials assessing general quality of life of OA patients.
12 months post baseline
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Tijdsspanne: 2 months post baseline
A 24-item questionnaire rating pain, stiffness, and physical functioning in everyday activities. It is the most widely used condition-specific quality of life measure for arthritis cost-effectiveness studies.
2 months post baseline
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Tijdsspanne: 12 months post baseline
A 24-item questionnaire rating pain, stiffness, and physical functioning in everyday activities. It is the most widely used condition-specific quality of life measure for arthritis cost-effectiveness studies.
12 months post baseline
Use of sleep and pain medications
Tijdsspanne: Baseline through 24 months
NSAID, analgesic, sedative, and anti-depressant medication use.
Baseline through 24 months
Outpatient visits
Tijdsspanne: Baseline through 24 months
The number of visits for OA, for sleep problems, and for visits irrespective of associated diagnosis.
Baseline through 24 months
Health care costs
Tijdsspanne: Baseline through 24 months
The Group Health cost database will be used to estimate costs (from study entry to 24 months post enrollment) of ambulatory healthcare for all conditions, arthritis and sleep problems, and inpatient care.
Baseline through 24 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

University of Washington

Medewerkers

Kaiser Permanente

Onderzoekers

  • Hoofdonderzoeker: Michael V Vitiello, PhD, University of Washington
  • Hoofdonderzoeker: Michael Von Korff, ScD, University of Washington
  • Hoofdonderzoeker: Kai Yeung, PhD, Kaiser Permanente

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start

1 oktober 2016

Primaire voltooiing (Werkelijk)

1 december 2019

Studie voltooiing (Verwacht)

1 november 2020

Studieregistratiedata

Eerst ingediend

19 oktober 2016

Eerst ingediend dat voldeed aan de QC-criteria

25 oktober 2016

Eerst geplaatst (Schatting)

27 oktober 2016

Updates van studierecords

Laatste update geplaatst (Werkelijk)

3 april 2020

Laatste update ingediend die voldeed aan QC-criteria

1 april 2020

Laatst geverifieerd

1 maart 2020

Meer informatie

Termen gerelateerd aan deze studie

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • 52176

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Klinische onderzoeken op Cognitive Behavior Therapy for Insomnia

Zoek naar vergelijkbare onderzoeken

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

CROs by country

CROs in Norway

Voorwaarden

Zeldzame ziekten

Geneesmiddelinterventies

Voedingssupplementen

Sponsor / medewerkers

Locaties

3
Abonneren